Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

rVSV-ZEBOV Ebola vaccine candidate set for Sierra Leone STRIVE trial

March 31, 2015

Trius divulges new gyrase inhibitors

March 31, 2015

Melinta Therapeutics patent new antimicrobials

March 31, 2015

Medivir present HCV polymerase NS5B inhibitors

March 30, 2015

Synflorix obtained Japanese approval as a pediatric pneumococcal conjugate vaccine

March 30, 2015

University of Illinois patent describes new antimicrobials

March 30, 2015

Ebola virus vaccines cAd3-EBOZ and VSV-ZEBOV appear to be safe in phase II trial

March 27, 2015

Aridis starts clinical development of monoclonal antibody against Pseudomonas aeruginosa

March 27, 2015

Daewoong Pharmaceutical presents novel antifungals

March 27, 2015

Lupin and Indian Rotary Club launch campaign against tuberculosis

March 27, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...